Researchers identify a "target" in the brain—such as a specific receptor—and design molecules to interact with it.
Initial efficacy testing in a small group of patients with the targeted condition.
The FDA examines all data to determine if the drug's benefits outweigh its risks. Download File Drug Development in Psychiatry.sa...
Post-market monitoring once the drug is available to the public.
Large-scale trials involving hundreds or thousands of patients to confirm efficacy and monitor adverse effects. Researchers identify a "target" in the brain—such as
Psychiatric drug development is notoriously difficult, with only about successfully transitioning from Phase I to approval.
Ongoing surveillance for rare or long-term side effects. Core Challenges in Psychiatry Post-market monitoring once the drug is available to
The drug development process in psychiatry is a multi-decade journey characterized by high scientific complexity, significant regulatory hurdles, and a historically low success rate compared to other medical fields.